Cancer Clinical Trial - Inhibrx - INBRX-109

Cancer

Status:

Open and enrolling

ClinicalTrials.gov:

NCT03715933

CONDITIONS(S): Pancreatic cancer, Gastric, Mesothelioma, Sarcoma - TRIAL: Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Drug

INBRX-109 + 5FU + Irinotecan

Trial Type

Treatment

Phase

Phase 1

Condition

Pancreatic cancer Gastric Mesothelioma Sarcoma

Keywords

Pancreatic cancer | Gastric | Mesothelioma | Sarcoma